granisetron hydrochloride (Sagent Pharmaceuticals)
Welcome to the PulseAid listing for the granisetron hydrochloride drug offered from Sagent Pharmaceuticals. This Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sagent Pharmaceuticals |
NON-PROPRIETARY NAME: | granisetron hydrochloride |
SUBSTANCE NAME: | GRANISETRON HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2010-12-01 |
END MARKETING DATE: | 0000-00-00 |
granisetron hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | granisetron hydrochloride from Sagent Pharmaceuticals |
LABELER NAME: | Sagent Pharmaceuticals |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.1(mg/mL) |
START MARKETING DATE: | 2010-12-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 25021-778_7957939e-e301-41cc-9737-88b0d1bddc84 |
PRODUCT NDC: | 25021-778 |
APPLICATION NUMBER: | ANDA091136 |
Other GRANISETRON HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: